{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:41:09Z","timestamp":1787787669284,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/V001027\/1"],"award-info":[{"award-number":["BB\/V001027\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008078","name":"University of Strathclyde","doi-asserted-by":"publisher","award":["BB\/V000993\/1"],"award-info":[{"award-number":["BB\/V000993\/1"]}],"id":[{"id":"10.13039\/100008078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008078","name":"University of Strathclyde","doi-asserted-by":"publisher","award":["MR\/V000683\/1"],"award-info":[{"award-number":["MR\/V000683\/1"]}],"id":[{"id":"10.13039\/100008078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.pt.2023.06.010","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T15:23:32Z","timestamp":1690039412000},"page":"739-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Conquering rheumatic diseases: are parasitic worms the answer?"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-5301","authenticated-orcid":false,"given":"Geraldine","family":"Buitrago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-3028","authenticated-orcid":false,"given":"Margaret M.","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9545-9401","authenticated-orcid":false,"given":"William","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2023.06.010_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2023.06.010_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases \u2013 evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.pt.2023.06.010_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.pt.2023.06.010_bb0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2023.06.010_bb0030","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20042321","article-title":"Impaired early B cell tolerance in patients with rheumatoid arthritis","volume":"201","author":"Samuels","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2023.06.010_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of synovial fibroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pt.2023.06.010_bb0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells' contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/08916934.2019.1700232","article-title":"The pathological role of B cells in systemic lupus erythematosus: from basic research to clinical","volume":"53","author":"Feng","year":"2020","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pt.2023.06.010_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413325","article-title":"B cell involvement in the pathogenesis of ankylosing spondylitis","volume":"22","author":"Wilbrink","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2023.06.010_bb0055","first-page":"S52","article-title":"Drug combinations with methotrexate to treat rheumatoid arthritis","volume":"28","author":"Rath","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0060","article-title":"Methotrexate for ankylosing spondylitis","volume":"4","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pt.2023.06.010_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0961203313519159","article-title":"Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy","volume":"23","author":"Sakthiswary","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.pt.2023.06.010_bb0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0075","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1038\/s41598-021-86729-7","article-title":"Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics","volume":"11","author":"Maciejewski","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2023.06.010_bb0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pt.2023.06.010_bb0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.47102\/annals-acadmedsg.V47N11p492","article-title":"Relapsing course of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by alopecia universalis and vitiligo","volume":"47","author":"Lian","year":"2018","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.pt.2023.06.010_bb0090","first-page":"417","article-title":"Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis","volume":"56","author":"Tarp","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.pt.2023.06.010_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/OI9.0000000000000092","article-title":"The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials","volume":"4","author":"Al Farii","year":"2021","journal-title":"OTA Int."},{"key":"10.1016\/j.pt.2023.06.010_bb0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.mehy.2013.03.042","article-title":"NSAIDs can have adverse effects on bone healing","volume":"81","author":"van Esch","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pt.2023.06.010_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002018-200629020-00002","article-title":"NSAID-associated adverse effects and acid control aids to prevent them","volume":"29","author":"Naesdal","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.pt.2023.06.010_bb0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/acr.23611","article-title":"Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis","volume":"71","author":"Wilson","year":"2019","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.pt.2023.06.010_bb0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.62.5.482","article-title":"Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis","volume":"62","author":"Aletaha","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pt.2023.06.010_bb0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.pt.2023.06.010_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-020-2100-y","article-title":"Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors \u2013 data from a large national quality register","volume":"22","author":"Cagnotto","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.pt.2023.06.010_bb0130","first-page":"141","article-title":"Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors","volume":"8","author":"Tanaka","year":"2014","journal-title":"Biologics"},{"key":"10.1016\/j.pt.2023.06.010_bb0135","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2665-9913(20)30033-3","article-title":"Lessons for rituximab therapy in patients with rheumatoid arthritis","volume":"2","author":"Garcia-Montoya","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0140","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.3390\/ijms232213913","article-title":"Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis","volume":"23","author":"Min","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2023.06.010_bb0145","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.pt.2023.06.010_bb0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2222.2005.02112.x","article-title":"Old friends for breakfast","volume":"35","author":"Rook","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.pt.2023.06.010_bb0155","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.34581","article-title":"The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites","volume":"64","author":"Pineda","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.pt.2023.06.010_bb0160","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/art.37883","article-title":"Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al","volume":"65","author":"Panda","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.pt.2023.06.010_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-3024.2006.00879.x","article-title":"Parasitic worms and inflammatory diseases","volume":"28","author":"Zaccone","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101477","article-title":"The epidemiology of established rheumatoid arthritis","volume":"33","author":"Ot\u00f3n","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0175","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0180","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00296-022-05183-4","article-title":"Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis","volume":"42","author":"Fatoye","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.pt.2023.06.010_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pt.2023.06.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001888","article-title":"Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades","volume":"7","author":"Crossfield","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.pt.2023.06.010_bb0195","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2016.10.010","article-title":"Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand","volume":"46","author":"McDougall","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.pt.2023.06.010_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0000000000001006","article-title":"Prevalence and incidence of rheumatoid arthritis in Canadian First Nations and non-First Nations people: a population-based study","volume":"26","author":"Hitchon","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0961203316662722","article-title":"Diminished IL-17A levels may protect filarial-infected individuals from development of rheumatoid arthritis and systemic lupus erythematosus","volume":"26","author":"Panda","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.pt.2023.06.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103979","article-title":"Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte\/macrophage polarization","volume":"25","author":"Cheng","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.pt.2023.06.010_bb0215","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fimmu.2018.01566","article-title":"Trichinella spiralis infection mitigates collagen-induced arthritis via programmed death 1-mediated immunomodulation","volume":"9","author":"Cheng","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12760","article-title":"Evaluating the preventive and curative effects of Toxocara canis larva in Freund's complete adjuvant-induced arthritis","volume":"42","author":"Shayesteh","year":"2020","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0225","article-title":"The impact of Clonorchis sinensis infection on immune response in mice with type II collagen-induced arthritis","volume":"42","author":"Li","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102057","article-title":"Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma","volume":"76","author":"Olia","year":"2020","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.pt.2023.06.010_bb0235","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/08916934.2014.929669","article-title":"Parasites alter the pathological phenotype of lupus nephritis","volume":"47","author":"Miyake","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pt.2023.06.010_bb0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trsl.2021.02.012","article-title":"A netrin domain-containing protein secreted by the human hookworm Necator americanus protects against CD4 T cell transfer colitis","volume":"232","author":"Buitrago","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.pt.2023.06.010_bb0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10787-021-00909-5","article-title":"Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis","volume":"30","author":"Langdon","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pt.2023.06.010_bb0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pathogens9060431","article-title":"Parasite cystatin: immunomodulatory molecule with therapeutic activity against immune mediated disorders","volume":"9","author":"Khatri","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.pt.2023.06.010_bb0255","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1007\/s00436-016-5140-0","article-title":"Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis","volume":"115","author":"Liu","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2023.06.010_bb0260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/mmr.2021.11912","article-title":"Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF-\u03baB signaling pathway","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pt.2023.06.010_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cei.12252","article-title":"Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis","volume":"177","author":"Pineda","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0270","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4049\/jimmunol.171.4.2127","article-title":"A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62","volume":"171","author":"McInnes","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/imm.12208","article-title":"Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints","volume":"141","author":"Rodgers","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.pt.2023.06.010_bb0280","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/art.38392","article-title":"ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints","volume":"66","author":"Pineda","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0285","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41598-017-01651-1","article-title":"Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62","volume":"7","author":"Lumb","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2023.06.010_bb0290","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fimmu.2018.01016","article-title":"Protection against arthritis by the parasitic worm product ES-62, and its drug-like small molecule analogues, is associated with inhibition of osteoclastogenesis","volume":"14","author":"Doonan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010069","article-title":"Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts","volume":"17","author":"Corbet","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2023.06.010_bb0300","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41467-019-09361-0","article-title":"The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis","volume":"10","author":"Doonan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2023.06.010_bb0305","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3390\/molecules23102669","article-title":"Failure of the anti-inflammatory parasitic worm product ES-62 to provide protection in mouse models of type I diabetes, multiple sclerosis, and inflammatory bowel disease","volume":"23","author":"Doonan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pt.2023.06.010_bb0310","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.40490","article-title":"Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation","volume":"70","author":"Jubair","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0315","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2023.06.010_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587534","article-title":"Regional differences in the gut microbiota and gut-associated immunologic factors in the ileum and cecum of rats with collagen-induced arthritis","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pt.2023.06.010_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953053","article-title":"The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing","volume":"13","author":"Harnett","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2023.06.010_bb0330","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/ard.2007.073502","article-title":"The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis","volume":"67","author":"Harnett","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pt.2023.06.010_bb0335","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.39004","article-title":"The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL\/lpr mice","volume":"67","author":"Rodgers","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.pt.2023.06.010_bb0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpara.2014.12.006","article-title":"The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model","volume":"45","author":"Aprahamian","year":"2015","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2023.06.010_bb0345","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/joim.13557","article-title":"Systemic lupus erythematosus and cardiovascular disease","volume":"293","author":"Frosteg\u00e5rd","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pt.2023.06.010_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.760980","article-title":"Therapeutic effect of Schistosoma japonicum cystatin on atherosclerotic renal damage","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pt.2023.06.010_bb0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pt.2009.12.003","article-title":"How do nematodes transfer phosphorylcholine to carbohydrates?","volume":"26","author":"Harnett","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2023.06.010_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1298473","article-title":"Immunogenicity of biotherapeutics: causes and association with posttranslational modifications","volume":"2016","author":"Kuriakose","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.pt.2023.06.010_bb0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2015.04.005","article-title":"Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1\u03b2 production via NRF2-mediated counter-regulation of the inflammasome","volume":"60","author":"Rzepecka","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.pt.2023.06.010_bb0370","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1021\/jm401251p","article-title":"Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis","volume":"56","author":"Al-Riyami","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2023.06.010_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200615","article-title":"Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis","volume":"13","author":"Blank","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2023.06.010_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00160-18","article-title":"Helminth-based product and the microbiome of mice with lupus","volume":"4","author":"Neuman","year":"2019","journal-title":"mSystems"},{"key":"10.1016\/j.pt.2023.06.010_bb0385","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1096\/fj.201901480RR","article-title":"Fasciola helminth defense molecule-1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response","volume":"34","author":"Khan","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.pt.2023.06.010_bb0390","series-title":"Helminth Infections and their Impact on Global Public Health","first-page":"607","article-title":"Can the study of parasitic helminths be fruitful for human diseases?","author":"Rzepecka","year":"2022"},{"key":"10.1016\/j.pt.2023.06.010_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. small molecules: drug costs and patient access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Med. Drug Discov."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492223001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492223001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:40:34Z","timestamp":1761464434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492223001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1471492223001460"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2023.06.010","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conquering rheumatic diseases: are parasitic worms the answer?","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2023.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}